Victrex报告,2025年有强劲的开端,收入增长9%,但在医疗销售方面面临挑战。 Victrex reports a strong start to 2025 with a 9% revenue increase but faces challenges in medical sales.

一家主要聚合物公司维克特雷克斯(Victrex)报告说,其2025财政年度有强劲的开端,第一季度收入增长9%,达到6 660万英镑,数量增长20%,达到898吨。 Victrex, a leading polymer company, reported a strong start to its fiscal year 2025 with a 9% revenue increase to £66.6 million and a 20% rise in volume to 898 tonnes in the first quarter. 尽管如此,由于行业库存量减少,医疗销售量仍然很低。 Despite this, medical sales remain low due to industry destocking. 尽管面临外汇挑战和新的设施费用,该公司预计现金流量会进一步改善,并维持本年度至少增长中位数的预测。 The company expects further cashflow improvement and maintains its forecast for at least mid-single digit volume growth for the year, despite foreign exchange challenges and new facility costs.